|Bid||29.34 x 900|
|Ask||29.92 x 800|
|Day's range||29.22 - 29.56|
|52-week range||15.65 - 47.84|
|Beta (5Y monthly)||0.47|
|PE ratio (TTM)||14.39|
|Earnings date||11 May 2021|
|Forward dividend & yield||1.90 (6.56%)|
|Ex-dividend date||30 Mar 2021|
|1y target est||28.00|
Kellogg's (K) first-quarter 2021 results reflect solid earnings and sales growth, along with a raised guidance for 2021. Strength in the retail business continues to aid.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Medifast's (MED) first-quarter 2021 results reflect robust earnings and sales growth. The company continued to gain on solid OPTAVIA performance, courtesy of a rise in active earning coaches.